AKT1 and diabetes mellitus: A recent study has demonstrated that upregulation of SNHG16 promotes diabetes-associated retinal vascular endothelial cell (RMEC) dysfunction by activating the NF-κB and PI3K/AKT pathways [18], but the exact mechanism remains unclear.